Michael Rapp, 10% Owner at Zynerba Pharmaceuticals, Inc. (ZYNE), bought 10,000 shares at $9.28 ($93K) on 2018-03-22, disclosed to the SEC on 2018-03-23.
Recurring purchase ($93k) by 10% Owner following this insider's established cadence. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| IMNM | BUY | 2021-05-26 | $1.9M | — | Filing → |
| IMNM | BUY | 2020-10-08 | $1000K | — | Filing → |
| ZYNE | BUY | 2018-05-31 | $123K | — | Filing → |